Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$2.74 0.0  0.4%

Last Trade - 15/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £4.60m
Enterprise Value £84.6k
Revenue £n/a
Position in Universe 6086th / 6547

BRIEF-Cellect Biotechnology Reports Q3 Loss Per Share $0.001

Fri 20th November, 2020 1:03pm
Nov 20 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS THIRD QUARTER FINANCIAL AND
OPERATING RESULTS; RECENT DEVELOPMENTS POSITION COMPANY TO
ACCELERATE PROGRESS IN 2021
    * Q3 LOSS PER SHARE $0.001
    * COMPANY'S CASH AND CASH EQUIVALENTS TOTALED $6.07 MILLION
AS OF
SEPTEMBER 30, 2020
    * HAS SUFFICIENT FUNDS TO OPERATE IN NEXT 15 MONTHS

Source text for Eikon:  ID:nGNX8BsfMy 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.